Neal J, Pavlakis N, Kim SW, Goto Y, et al. CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non-Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy. J Clin Oncol 2024 Mar 29:JCO2302166. doi: 10.1200/JCO.23.02166.
PMID: 38552197